Aton (ALTAO) Stock Overview
Operates as a bioscience company in France. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
ALTAO Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Aton Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.006 |
| 52 Week High | €0.011 |
| 52 Week Low | €0.005 |
| Beta | 0.28 |
| 1 Month Change | -11.76% |
| 3 Month Change | -25.00% |
| 1 Year Change | -40.00% |
| 3 Year Change | -90.35% |
| 5 Year Change | -97.25% |
| Change since IPO | -94.41% |
Recent News & Updates
Recent updates
Shareholder Returns
| ALTAO | FR Biotechs | FR Market | |
|---|---|---|---|
| 7D | -18.9% | -8.4% | 1.1% |
| 1Y | -40.0% | 322.1% | 8.9% |
Return vs Industry: ALTAO underperformed the French Biotechs industry which returned 320.9% over the past year.
Return vs Market: ALTAO underperformed the French Market which returned 8.9% over the past year.
Price Volatility
| ALTAO volatility | |
|---|---|
| ALTAO Average Weekly Movement | 10.4% |
| Biotechs Industry Average Movement | 8.6% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in FR Market | 10.3% |
| 10% least volatile stocks in FR Market | 2.3% |
Stable Share Price: ALTAO's share price has been volatile over the past 3 months compared to the French market.
Volatility Over Time: ALTAO's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of French stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 9 | Ayikoele Atayi | www.aton-group.com |
Aton operates as a bioscience company in France. It engages in drug development, preclinical and clinical services, production of monoclonal antibodies, laboratory equipment production, and designing and manufacturing of medical devices, as well as provision of human tissues. The company also offers medical devices for surgeons, powered by Stemcis.
Aton Fundamentals Summary
| ALTAO fundamental statistics | |
|---|---|
| Market cap | €4.97m |
| Earnings (TTM) | -€115.68k |
| Revenue (TTM) | €656.93k |
Is ALTAO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALTAO income statement (TTM) | |
|---|---|
| Revenue | €656.93k |
| Cost of Revenue | €247.90k |
| Gross Profit | €409.03k |
| Other Expenses | €524.71k |
| Earnings | -€115.68k |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.00014 |
| Gross Margin | 62.26% |
| Net Profit Margin | -17.61% |
| Debt/Equity Ratio | 488.3% |
How did ALTAO perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/01/06 17:37 |
| End of Day Share Price | 2026/01/06 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Aton is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.